Trial
NCT06420349
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Advanced Cholangiocarcinoma
Intervention
Biospecimen Collection
Why stopped
study sponsor phasing out drug supply
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-22